to

4th International Medical Cannabis Conference

By:

Rokach Blvd 101,
Tel Aviv-Yafo, 6121002, Israel

Details

Your access to the most relevant developments, innovations, and opportunities in medical cannabis

A rapidly growing and evolving field, medical cannabis is taking center-stage for scientists, clinicians, entrepreneurs, investors, policy makers and thought leaders around the globe. First-hand knowledge and networks are essential in understanding the way forward within this complex ecosystem. CannX is the ultimate place to gain a deep understanding of what is truly ground-breaking in research, business, agriculture and technology. It is where connections are formed, ideas are exchanged, and opportunities move forward.

Features

Three Dynamic Tracks
Explore sessions from three dynamic tracks, covering the full-range of topics essential for all leaders in today’s medical cannabis scene.

SCI
Access the cutting-edge science driving the next wave of developments. Noted researchers and practitioners will present their latest findings.

BIZ
Gain unparalleled insight into the future of business for local and global markets. We will delve into opportunities, pitfalls and the how-to for smart-investments in medical cannabis.

AGR
Stay ahead of competition as the world supply chain develops. CannX will feature new technology, systems and solutions designed to help farmers succeed.

Program

09:00 Sep 9
REGISTRATION & WELCOME COFFEE
10:00 Sep 9
OPENING SESSION
10:30 Sep 9
Keynote Lecture: THE CANNABINOID SYSTEM: WHERE DO WE STAND TODAY?
Raphael Mechoulam, Institute for Drug Research, The Hebrew University of Jerusalem, Israe
11:00 Sep 9
COFFEE BREAK & POSTER VIEWING & EXHIBITION VISIT
11:30 Sep 9
CANNABIS AND THE OPIOD EPIDEMIC
Shaul Lev Ran, Director of Addiction Medicine and Dual Disorders Clinic, Tel Aviv University, Israel, David Casarett, Prof. Chief of Palliative Care, Duke University, USA, Philippe Lucas, VP of Patient Research and Access, Tilray, Canada
12:15 Sep 9
FIVE MINUTE TECHNICAL BREAK
12:20 Sep 9
THE ISRAEL MODEL: A SMALL COUNTRY, A LEADING INDUSTRY
Kobi Caspi, Co-founder and CFO, Cann10, Israel, Ori Alperowitz, CEO, Cann10, Israel, Amir Goldstein, Cheif Operations Officer, IMC, Israel, Itai Rogel, Head of Business Development, Bazelet Group, Israel
12:20 Sep 9
PANEL DISCUSSION: CANNABIS TREATMENT AS AN EXIT STRATEGY – TO SUBSTITUTE FOR OPIOIDS, ALCOHOL AND OTHER DRUGS
Shaul Lev Ran, Prof. Director of Addiction Medicine and Dual Disorders Clinic, Tel Aviv University, Israel, Elyad Davidson, Prof. Director, Pain Relief Unit at Hadassah Hebrew University Medical Center, Israel...
12:20 Sep 9
CANNABIS GENETICS – NEW DEVELOPMENTS
Shay Sarid, Co-Founder & CTO, Seach Medical Cannabis Group, Israel, Jonathan Page, Chief Sceintist, Aurora, Canada, Avner Shenfeld, Epigenetics Ltd., Israel, Arnon Heyman, CEO, Canonic Ltd., Israel
13:30 Sep 9
LUNCH BREAK, EXHIBITION VISIT & POSTER PRESENTATIONS
14:30 Sep 9
THE IMPACT OF CANNABIS BASED TREATMENT ON VARIOUS DISEASES-PRE CLINICAL AND CLINICAL RESULTS
Reuven Or, Prof MD Cancer Immunotherapy & Immunobiology Research Center, Hadassah University Hospital, Israel
14:30 Sep 9
DYSREGULATION OF THE ENDOCANNABINOID SYSTEM IN HUMAN PHYSIOLOGY
Yossi Tam, Dr., Head, Obesity and Metabolism Laboratory, The Institute for Drug Research, Faculty of Medicine, Director, Multidisciplinary Center on Cannabinoid Research, The Hebrew University of Jerusalem, Israel
14:50 Sep 9
ROLE OF CANNABIDIOLIC ACID-METHY ESTER (CBDA-ME) IN A PRECLINICAL MODEL OF PERIPHERAL NEUROPATHIC PAIN
Gurmit Singh, Prof., Pathology and Molecular Medicine, Singh laboratory McMaster University
15:05 Sep 9
NEUROLOGICAL: THE IMPACT OF CANNABIS ON PARKINSON RELATED SYMPTOMS
Ruth Djaldetti, Prof., Movement Disorder Clinic, Department of Neurology, Rabin Medical Center, Petach Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Israel
15:20 Sep 9
THE EFFECT OF CANNABIS VS. PLACEBO ON DEMENTIA PATIENTS
Vered Hermush, Dr, Medical Director, Geriatric Wing Company NameLaniado Hospital, Israel
15:35 Sep 9
PAIN RECEPTORS: THE IONOTROPIC CANNABINOIDS RECEPTORS
Avi Priel, Dr., Head, Lab of Molecular Pharmacology of Somatosensation and Pain, Israel
15:50 Sep 9
THE HIGHS AND LOWS OF CANNABIS TREATMENT IN CANCER PATIENTS
Reuven Or, M.D. Bone Marrow Transplantation, Cancer Immunotherapy & Immunobiology Research Center, Hadassah University Hospital, Israel and Osnat Almogi-Hazan, M.D., Cancer Immunotherapy & Immunobiology Research Center,Hadassah University Hospital, Israel
14:30 Sep 9
DIGITAL HEALTH AND CANNABIS – IS THE FUTURE HERE? BIG DATA, PREDICTION, AND ARTIFICIAL INTELLIGENCE
Gali Weinreb, Editor and Biomed correspondent, Globes, Israel, Itzhak Kurek, CEO and Co-Founder, Cannformatics Inc., USA, David Berg, President and CTO, Strainprint Technologies Ltd., Canada, Avihu Tamir, CEO, Kanabo Research, Israel
14:30 Sep 9
DRUG DELIVERY
Hadile Ounallah-Saad, VP R&D, Cannassure, Israel, Martin Chasen, Vice President Clinical Programs Medical Affairs, Tetra Bio-Pharma, Canada, Hadile Ounallah-Saad, VP R&D, Cannassure, Israel, Jeremy Riggle, Chief Scientist, Mary’s Medicinals, USA
16:05 Sep 9
HAPPY HOUR
09:00 Sep 10
PARALLEL SESSIONS: ORAL PRESENTATIONS: SCIENCE, BUSINESS/SCIENCE & AGRICULTURE/SCIENCE
10:00 Sep 10
PHYTO AND ENDOCANNABINOIDS – HOW TO COMBINE THE TWO FOR SYNERGETIC UNDERSTANDING
Lumír Ondřej Hanuš, Prof.,Chief Scientist, Lumir Labs, Israel and David (Dedi) Meiri, Ph.D, Head of the Laboratory of Cancer Biology and Cannabinoid Research, Israel
10:00 Sep 10
KEYNOTE LECTURE: IS OUR CURRENT KNOWLEDGE ON TREATMENT WITH CANNABIS SUFFICIENT?
Lumír Ondřej Hanuš, Prof. Chief Scientist, Lumir Labs, Israel
10:25 Sep 10
THE ORCHESTRA OF THE PHYTOCANNABINOIDS
David (Dedi) Meiri, Prof. Head of Scientific Advisory Board, Technion, Institute of Technology, Israel
10:50 Sep 10
CAN WE REGULATE THE PHYTOCANNABINOID PROFILE?
Nirit Bernstein, Ph.D., Department Head, Soil Physics and Irrigation Institute of Soil Water and Environmental Sciences Volcani Center, Israel
11:10 Sep 10
THE NEXT STEP IN CANNABIS TREATMENT: THE BENEFITS OF CANNABIS MICRO DOSING-TURNING THE CLOCK: THE ENDOCANNABINOID SYSTEM AND AGEING
Andreas Zimmer,Prof., Director, Institute of Molecular Psychiatry University of Bonn, Germany
10:00 Sep 10
ENTERING THE PHARMACEUTICAL INDUSTRY – HOW TO MEET PHARMA STANDARDS IN CANNABIS BASED PRODUCTS
Orna Dreazen, CEO and Chairperson of the Board of Directors, Nextar Chempharma Solutions Ltd., Israel
10:00 Sep 10
THC VS. CBD – TRIANGLE RELATIONSHIP: REGULATION, RESEARCH & INDUSTRY
Heli Dangur, Director of Global Business Development, Cann10, Israel, Miles Gilman, President, Sunhealth Therapeutic, USA, Dror Robinson, Chairman of the Israeli Association of Cannabis Medicine, Israel
10:40 Sep 10
DEBATE: WILL THE HEMP INDUSTRY TAKEOVER?
Heli Dangur, Director of Global Business Development, Cann10, Israel, Clifton Flack, Founder, Ciitech, Israel, Maayan Weisberg Joels, Business Development Manager, Tikun Olam, Israel
12:00 Sep 10
TREATING AUTISM WITH MEDICAL CANNABIS
Adi Aran, Dr., Director of the Neuro-pediatric unit, Shaare Zedek Medical Center Jerusalem, Israel
12:00 Sep 10
KEYNOTE LECTURE: RANDOMIZED STUDY OF CANNABINOID TREATMENT IN CHILDREN WITH ASD
Adi Aran, Dr. Director of the Neuro-pediatric unit, Shaare Zedek Medical Center Jerusalem, Israel
12:20 Sep 10
PANEL DISCUSSION
Adi Aran, Dr., Director of the Neuro-pediatric unit, Shaare Zedek Medical Center Jerusalem, Israel, Orit Stolar, Dr., Pediatric Neurologist, Assaf Harofeh Medical Center, Israel, Abigail Dar, Founder and CEO, CannaFora Center, Israel
13:00 Sep 10
LUNCH BREAK, POSTER VIEWING & EXHIBITION VISIT, CANNXL STARTUP AWARD AUDIENCE VOTE
14:00 Sep 10
FROM SMOKING TO NANO TECHNOLOGIES – NEW FINDINGS ON EFFECTIVE DRUG DELIVERY
Chair: Yossi Tam, Dr., Head, Obesity and Metabolism Laboratory, The Institute for Drug Research, Faculty of Medicine ,Director, Multidisciplinary Center on Cannabinoid Research, The Hebrew University of Jerusalem, Israel
14:00 Sep 10
NANO-DELIVERY SYSTEMS MAY IMPROVE THE PERFORMANCE OF CANNABINOIDS
Simon Benita, Prof. Emeritus, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine The Hebrew University of Jerusalem, Israel
14:15 Sep 10
IMPROVED BIOAVAILABILITY OF CANNABINOIDS
Abraham J Domb, PhD. Head of Biopolymers and Pharmaceutical Chemistry Lab, Leonel Jacobson, Israel
14:30 Sep 10
NOVEL NANODOMAINS AS VEHICLES FOR ENHANCED DELIVERY FOR CANNABINOIDS
Nissim Garti, Prof.,Ph.D Ratner Chair of Chemistry Head of Casali Center of Applied Chemistry Nanoscience and Nanotechnology Center Head of Innovation Forum of Food Technology Institute of Chemistry The Hebrew University of Jerusalem, Israel
15:45 Sep 10
DEBATE: AN EVIDENCE-BASED MEDICINE VS PRACTICE-DRIVEN DATA BASED CANNABINOID MEDICINE
Yuval (Tuby) Zolotov, Dr., Network and Partnership Coordinator, International Association for Cannabinoid Medicine, Israel, Michael Dor, Dr. The medical consultant of the medical cannabis unit at the Health Ministry, Israel...
14:00 Sep 10
GLOBAL TRADE: OVERCOMING IMPORT-EXPORT BARRIERS IN A CONSTANTLY CHANGING REGULATORY ENVIRONMENT
Lior Kenan, Economics Correspondant, Chanel 13, Israel
14:45 Sep 10
HIGH-END TECHNOLOGIES FOR BEST CULTIVATION AND PLANT PROTECTION
Gilad Livni, Cannabis Consulted Breeder, Israel, Zohar Levy, CEO, Seedo Lab, Israel, Ofer Finkelstein, VP Sales, Juganu, Israel
15:30 Sep 10
COFFEE BREAK & POSTER VIEWING & EXHIBITION VISIT
16:00 Sep 10
THE MEDICAL CANNABIS CAPITAL MARKET – HOW TO ASSESS THE TRUE VALUE OF A COMPANY?
Sophie Shulman, Capital Markets Editor, Calcalist, Israel, Steve Hawkins, President and CEO, Horizons ETFs, Canada, Shiry Eden, Founder and CEO, Nishot, Israel, Yossi Bornstein, Founder and Partner, Shizim Group and Cann10, Israel
17:15 Sep 10
CLOSING ADDRESS

Tickets